These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 119354)

  • 1. The disposition of the synthetic prostaglandin analogue cloprostenol ('Estrumate') in the rat and marmoset.
    Bourne GR; Moss SR; Phillips PJ; Shuker B
    Xenobiotica; 1979 Oct; 9(10):623-31. PubMed ID: 119354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic fate of the synthetic prostaglandin cloprostenol ('Estrumate') in the cow: use of ion cluster techniques to facilitate metabolite identification.
    Bourne GR; Moss SR; Phillips PJ; Shuker B
    Biomed Mass Spectrom; 1980 May; 7(5):226-30. PubMed ID: 7417700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion cluster techniques in drug metabolism: an example of the use of mixtures of the [12C]:[14C] isotopic forms of the synthetic prostaglandin cloprostenol ('Estrumate') to facilitate metabolite identification.
    Bourne GR; Moss SR; Phillips PJ; Webster JT; White DF
    Biomed Mass Spectrom; 1979 Aug; 6(8):359-60. PubMed ID: 497363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism of the anti-inflammatory drug eterylate in rat, dog and man.
    Wood SG; John BA; Chasseaud LF; Johnstone I; Biggs SR; Hawkins DR; Priego JG; Darragh A; Lambe RF
    Xenobiotica; 1983 Dec; 13(12):731-42. PubMed ID: 6144210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of latanoprost in the cynomolgus monkey. 2nd communication: repeated topical administration on the eye.
    Sjöquist B; Uhlin A; Byding P; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):234-9. PubMed ID: 10219467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic disposition of 14C-labelled carmoisine in the rat, mouse and guinea-pig.
    Phillips JC; Bex C; Walters DG; Gaunt IF
    Food Chem Toxicol; 1987 Dec; 25(12):927-35. PubMed ID: 3692400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey.
    Kanai Y; Nakai Y; Nakajima N; Tanayama S
    Xenobiotica; 1979 Jan; 9(1):33-50. PubMed ID: 104449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic fate of 14C-ximoprofen in rats, baboons and humans.
    Mayo BC; Chasseaud LF; Hawkins DR; Taylor IW; Legeai J
    Xenobiotica; 1990 Mar; 20(3):233-46. PubMed ID: 2336835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of metabolism and clearance studies with 14C-cloprostenol in the cow.
    Bourne GR
    Acta Vet Scand Suppl; 1981; 77():5-9. PubMed ID: 6946699
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.
    DeLong AF; Martin GP; Polk A; Carter V; Herczeg T
    Arzneimittelforschung; 1978; 28(8a):1477-80. PubMed ID: 113016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disposition and metabolism of the synthetic prostaglandin fluprostenol (ICI 81,008) in the horse.
    Chapman DI; Moss MS; Tomlinson PW; Harrison MP; Simmons PJ
    Xenobiotica; 1980 Sep; 10(9):715-23. PubMed ID: 7445532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a synthetic prostaglandin analogue, cloprostenol, on the corpus luteum of the guinea pig.
    Azmi TI; O'Shea JD; Lee CS; Rodgers RJ
    Prostaglandins; 1982 Oct; 24(4):519-26. PubMed ID: 6891084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
    John BA; Chasseaud LF; Wood SG; Forlot P
    Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.
    Maurer G; Schreier E; Delaborde S; Nufer R; Shukla AP
    Eur J Drug Metab Pharmacokinet; 1983; 8(1):51-62. PubMed ID: 6861794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and pharmacokinetic studies following oral administration of famciclovir to the rat and dog.
    Filer CW; Ramji JV; Allen GD; Brown TA; Fowles SE; Hollis FJ; Mort EE
    Xenobiotica; 1995 May; 25(5):477-90. PubMed ID: 7571721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition in rats and dogs of ciglitazone, a new antidiabetic agent.
    Torii H; Yoshida K; Tsukamoto T; Tanayama S
    Xenobiotica; 1984 Mar; 14(3):259-68. PubMed ID: 6711015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of iloprost and cicaprost in mice.
    Hildebrand M
    Prostaglandins; 1992 Nov; 44(5):431-42. PubMed ID: 1281921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset.
    Hackett AM; Griffiths LA
    Drug Metab Dispos; 1981; 9(1):54-9. PubMed ID: 6111433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.